24.4 Peri-Implant Disease and Systemic Risk Factors

5. Peri-Implant Diseases and Conditions

With dental implants representing a standard restorative modality in the UK, understanding peri-implant pathology is mandatory for the ORE Part 1 examination.

Natural Tooth vs Dental Implant Periodontal Architecture
  ┌───────────────────────────────────────────────┬───────────────────────────────────────────────┐
  │                 Natural Tooth                 │                Dental Implant                 │
  ├───────────────────────────────────────────────┼───────────────────────────────────────────────┤
  │ Sharpey's fibres insert perpendicularly into  │ No Sharpey's fibres; collagen fibres run      │
  │ root cementum (Physical mechanical barrier).  │ parallel / circular to titanium surface.      │
  │ Rich vascular supply from PDL, alveolar bone, │ Hypovascular, hypocellular scar-like cuff;   │
  │ and supraperiosteal vessels.                  │ vascular supply derived solely from bone/peri.│
  │ High probing resistance; probe tip stops      │ Lower probing resistance; probe tip routinely │
  │ coronal to connective tissue attachment.      │ penetrates deeper into connective zone.       │
  │ Periodontal ligament space (Physiological     │ Direct bone-to-implant contact (Osseointeg-   │
  │ mobility, sensory proprioception).            │ ration); no PDL, zero physiological mobility. │
  └───────────────────────────────────────────────┴───────────────────────────────────────────────┘

Diagnostic Criteria for Peri-Implant Pathology

1. Peri-Implant Health: Absence of clinical signs of erythema, oedema, bleeding on probing, and suppuration. Stable probing depths over time. Absence of progressive marginal bone loss beyond initial physiological bone remodeling following implant placement.
2. Peri-Implant Mucositis: Biofilm-induced inflammatory lesion confined strictly to the peri-implant mucosal cuff without loss of supporting crestal bone. Manifests as bleeding on gentle probing (BOP) and/or erythema and oedema. Reversible upon effective professional plaque removal.
3. Peri-Implantitis: A plaque-associated pathological condition occurring in tissues around dental implants, characterized by mucosal inflammation (profuse BOP and/or suppuration), increased probing pocket depths relative to baseline examination, and progressive loss of supporting crestal alveolar bone extending beyond physiological remodelling.

[!IMPORTANT] Diagnostic Thresholds in the Absence of Baseline Radiographs / Records: If initial baseline radiographs and probing depths post-reconstruction are unavailable, a definitive diagnosis of Peri-Implantitis is established by:

• Presence of profuse bleeding on probing (BOP) and/or suppuration; AND
• Probing pocket depths of $\ge 6\text{ mm}$; AND
• Radiographic crestal bone levels situated $\ge 3\text{ mm}$ apical to the most coronal portion of the intraosseous component of the implant.

6. Systemic Risk Factors: Tobacco Smoking and Diabetes Mellitus

Tobacco Smoking: Cellular and Vascular Pathophysiology

Tobacco smoking is the single most significant environmental risk factor for the development, progression, and treatment failure of periodontitis. It displays a clear dose-response relationship.

                              Tobacco Smoking (Nicotine)
                                         │
        ┌────────────────────────────────┼────────────────────────────────┐
        ▼                                ▼                                ▼
Peripheral Vasoconstriction      Immune Dysregulation             Tissue Destruction
  - Blunts erythema/BOP            - Impaired PMN chemotaxis        - Suppressed fibroblasts
  - Masks clinical signs           - Defective phagocytosis         - Decreased collagen I
  - Gingiva appears pink/fibrotic  - Reduced serum IgG2             - Upregulated MMP-8/9
                                   - Anaerobic shift (P.g., T.f.)   - Rapid alveolar RBL

1. Vascular Suppression (The Clinical Masking Effect): Nicotine stimulates peripheral sympathetic ganglia and alpha-1 adrenergic receptors, inducing profound local microvascular vasoconstriction. Consequently, smokers exhibit significantly reduced gingival bleeding on probing, decreased crevicular fluid flow, and pale, fibrotic gingival margins, even in the presence of severe, deep subgingival destructive periodontitis. This clinical masking frequently leads to delayed presentation and underdiagnosis.
2. Impairment of Host Polymorphonuclear Neutrophils (PMNs): While smokers often exhibit elevated systemic neutrophil counts, these cells display severely compromised chemotactic migration, diminished trans-endothelial diapedesis, and impaired bacterial phagocytosis and oxidative burst killing.
3. Humoral Immunosuppression: Smokers demonstrate significantly depressed serum concentrations of IgG2, the primary protective immunoglobulin subclass directed against polysaccharide capsular antigens of periodontal pathogens like Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans.
4. Microbial Dysbiosis: The reduced local oxidation-reduction potential ($Eh$) within the subgingival pocket selects for an earlier, more extensive colonisation by virulent anaerobic "red complex" pathogens (P. gingivalis, Tannerella forsythia, Treponema denticola).
5. Fibroblast and Osteoblast Inhibition: Nicotine binds directly to root surfaces, inhibiting periodontal ligament fibroblastic proliferation, spreading, and collagen synthesis, while upregulating host matrix metalloproteinases (MMP-1, MMP-8, MMP-9) and stimulating osteoclastic bone resorption via elevated RANKL expression.

Diabetes Mellitus: The Hyper-Inflammatory Paradigm

Diabetes mellitus exhibits a robust, bi-directional relationship with periodontitis: poorly controlled diabetes accelerates periodontitis severity, while severe active periodontitis impairs systemic glycaemic control.

                         Chronic Hyperglycaemia
                                   │
                                   ▼
          Accumulation of Advanced Glycation End-Products (AGEs)
                                   │
                                   ▼
         Binding to RAGE on Macrophages, Monocytes & Endothelium
                                   │
                                   ▼
          Activation of NF-κB Transcription Signaling Pathway
                                   │
        ┌──────────────────────────┴──────────────────────────┐
        ▼                                                     ▼
Hyper-Inflammatory Cytokine Storm                     Microvascular Alterations
  - Massive release of TNF-α, IL-1β, IL-6               - Endothelial basement membrane thickening
  - Massive upregulation of RANKL (Overwhelms OPG)      - Impaired trans-capillary nutrient exchange
  - Uncontrolled osteoclastogenesis & rapid RBL         - Compromised leukocyte emigration

1. The AGE-RAGE Axis: In sustained hyperglycaemia, circulating glucose binds non-enzymatically to collagen, structural proteins, and lipoproteins, forming stable, irreversible Advanced Glycation End-products (AGEs). AGEs bind with high affinity to the Receptor for AGE (RAGE) expressed abundantly on the membranes of monocytes, macrophages, endothelial cells, and osteoblasts.
2. The Cytokine Storm: Ligation of RAGE triggers activation of nuclear factor kappa B (NF-κB), driving transcription and uncontrolled systemic release of pro-inflammatory cytokines: Tumour Necrosis Factor-alpha (TNF-α), Interleukin-1 beta (IL-1β), Interleukin-6 (IL-6), and Prostaglandin E2 ($PGE_2$). Monocytes from diabetic patients adopt a hyper-inflammatory phenotype, producing up to three to four times more inflammatory mediators in response to bacterial lipopolysaccharide (LPS) than non-diabetic controls.
3. Altered Bone Turnover (RANKL / OPG Ratio): TNF-α and IL-1β markedly upregulate the expression of RANKL (Receptor Activator of Nuclear Factor-κB Ligand) on osteoblasts and T-lymphocytes, while simultaneously suppressing Osteoprotegerin (OPG), the physiological decoy receptor. The resulting spike in the RANKL/OPG ratio drives uninhibited differentiation, activation, and survival of multinucleated osteoclasts, causing accelerated, extensive alveolar bone resorption.
4. Microvascular Pathophysiology: Diabetic microangiopathy induces diffuse thickening and cross-linking of the vascular endothelial basement membrane. This impedes trans-capillary oxygen diffusion, nutrient delivery, and metabolic waste removal, while blunting PMN diapedesis into the gingival crevice and stalling wound repair.
5. The Bi-Directional Impact on Glycaemic Control: Periodontal infection acts as a chronic systemic inflammatory focus. The systemic dissemination of periodontopathic bacteria, endotoxins, and pro-inflammatory mediators (specifically TNF-α and IL-6) into the systemic circulation induces peripheral insulin resistance by downregulating insulin receptor substrate-1 (IRS-1) phosphorylation in skeletal muscle and adipose tissue. High-quality randomised controlled trials demonstrate that successful non-surgical periodontal therapy (Step 1 and Step 2 debridement) yields an average reduction in HbA1c of approximately $0.4%$ ($4\text{ mmol/mol}$) at 3 to 4 months—a therapeutic improvement clinically equivalent to adding a second oral hypoglycaemic pharmacotherapy.

7. Clinical Traps, Pitfalls, and Worked Scenarios

[!CAUTION] Clinical Trap: The "Pink, Firm Gingiva" in Heavy Smokers: A 46-year-old patient who smokes 20 cigarettes per day attends for a routine examination. Visual inspection reveals pale, coral-pink gingival margins with zero obvious oedema, knife-edged margins, and a bleeding on probing score of only 4%. A novice practitioner might mistake this presentation for clinical periodontal health and record BPE Codes of 0 or 1. However, full-mouth probing reveals generalized probing pocket depths of 6 to 8 mm with extensive interdental attachment loss and radiographic bone loss reaching the apical third of multiple teeth. The local vasoconstrictive and immunosuppressive effects of nicotine have completely suppressed inflammatory erythema and bleeding. Never rely on visual appearance or absence of bleeding in smokers; thorough periodontal probing is non-negotiable.

[!WARNING] Clinical Trap: Confounding Pseudopockets with True Periodontitis: A 52-year-old hypertensive patient taking amlodipine (10 mg daily) presents with generalized 5 to 6 mm probing depths around all teeth. Bitewing radiographs demonstrate pristine alveolar bone levels situated 1 mm apical to the cemento-enamel junction across the entire dentition. Calculating attachment loss reveals that the gingival margin is located 3 mm coronal to the CEJ (gingival overgrowth). True Clinical Attachment Loss (CAL) is zero ($ ext{CAL} = ext{PPD } 6 ext{ mm} - ext{Overgrowth } 3 ext{ mm} = 0 ext{ mm}$ attachment loss at the CEJ). Diagnosing this patient with Stage III periodontitis and performing aggressive subgingival root planing is a diagnostic error. The correct diagnosis is Drug-Induced Gingival Enlargement (DIGE) on an intact periodontium with gingival pseudopocketing.

Worked Clinical SBA Scenario

Scenario: A 48-year-old female presents to your clinic complaining of loose lower front teeth and persistent halitosis. She reports smoking 15 cigarettes per day for 25 years. Clinical examination reveals generalized interdental clinical attachment loss of 5 to 6 mm at multiple teeth. Probing pocket depths range between 5 and 7 mm. Tooth 46 exhibits 6 mm of attachment loss and Grade II furcation involvement. Periapical radiographs demonstrate horizontal and vertical bone loss extending to 48% of the root length at tooth 46. She has lost teeth 16 and 26 due to periodontal mobility three years ago, but retains 26 functional teeth with no secondary occlusal collapse or masticatory dysfunction. Medical history reveals well-controlled asthma, with normal glycaemic indices.

Question: What is the definitive periodontal diagnosis according to the 2018 EFP/AAP Classification as implemented by the British Society of Periodontology?

Clinical Reasoning Formulation:

1. Case Definition: The patient exhibits interdental CAL $\ge 5\text{ mm}$ at multiple non-adjacent teeth not attributable to trauma or caries. She is a confirmed case of periodontitis.
2. Staging: The maximum interdental CAL is $\ge 5\text{ mm}$ (worst site $6\text{ mm}$ at tooth 46), radiographic bone loss extends into the middle third ($48%$, exceeding $33%$), there are vertical defects and Class II furcation involvement, and tooth loss due to periodontitis is 2 teeth (which is $\le 4\text{ teeth}$). Because she retains $> 20$ teeth without bite collapse, secondary occlusal trauma, or flaring, this meets all criteria for Stage III (and has not progressed to Stage IV complexity).
3. Grading: Calculating indirect evidence via bone loss / age: $\frac{48%\text{ RBL}}{48\text{ years of age}} = 1.00$. A ratio of $1.00$ sits at the boundary of Grade B/C. However, the patient is a heavy cigarette smoker consuming 15 cigarettes per day ($\ge 10\text{ cigarettes/day}$). Under the grading framework, smoking $\ge 10$ cigarettes daily is an automatic grade modifier that mandates assignment of Grade C.
4. Extent: Generalized interdental attachment loss and pocketing affects $\ge 30%$ of the remaining dentition, classifying the extent as Generalised.
5. Definitive Diagnosis: Generalised Periodontitis; Stage III, Grade C; currently unstable; active risk factor: cigarette smoking (15/day).